Last reviewed · How we verify

NCT04756739

Menstrual Cycle Symptom Tracking

Completed Last updated 12 January 2022
What this trial tests

trial testing Clearblue Connected Ovulation Test System in Menstrual Cycles in 104 participants. Completed in 10 September 2021.

Timeline
22 February 2021
Primary endpoint
10 September 2021
10 September 2021

Quick facts

Lead sponsorSPD Development Company Limited
StatusCompleted
Study typeOBSERVATIONAL
Enrollment104
Start date22 February 2021
Primary completion10 September 2021
Estimated completion10 September 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

SPD Development Company Limited

Who can join

18 and older, female only, with Menstrual Cycles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide menstrual cycle symptom information from women over the course of three menstrual cycles to determine whether there are any noticeable physiological changes that can be related to stage of the menstrual cycle or onset of menstruation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Clearblue Connected Ovulation Test System

Trials testing the same drug.

Other recruiting trials for Menstrual Cycles

Currently open trials in the same condition.

Other SPD Development Company Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04756739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing